CERENOVUS News & Events

Johnson & Johnson Announces CE Mark for CEREGLIDE™ 42, CEREGLIDE™ 57, CEREGLIDE™ 71 and INNERGLIDE™ 7

Johnson & Johnson Advances Neurovascular Innovation at ESMINT 2025

04 September 2025

CERENOVUS Launches EMBOGUARD™ Balloon Guide Catheter to Use in the Treatment of Acute Ischemic Stroke in Europe

05 September 2024

CERENOVUS CG71

CERENOVUS Launches Next Generation Catheter to Treat Acute Ischemic Stroke in Europe

Patrick Brouwer, and 3 colleagues in the lab in white coats

The Neuro Thromboembolic Initiative: Addressing the science behind clots.

07 October 2022

Mahmood Mirza and 4 colleagues in the lab in white coats and masks.

Stroke Science: From Lab to Life. “As research engineers we are inspired by the challenge of enabling physicians to give patients the best possible clinical outcome.”

28 September 2022

Stroke Science: From Lab to Life.

Stroke Science: From Lab to Life. “That’s what I want to tell young women: try until you succeed. If you're really passionate about something, don't give up.” Anushree Dwivedi PhD, Research & Development Engineer, CERENOVUS

sarah johnson holding award

Clot science: from lab to life. “I have seen the devastating impact that stroke can have – so knowing that our devices are helping people really drives me.” Sarah Johnson, PhD.

25 October 2021

CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment

CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment

09 September 2020

fighting stroke together hero image

Fighting Stroke Together

29 October 2019

BRAVO Flow Diverter

CERENOVUS Receives European Regulatory Approval For BRAVO Flow Diverter to Treat Intracranial Aneurysms

CERENOVUS

NEW STUDY SHOWS USE OF EMBOTRAP® DEVICE CLOT RETRIEVER DURING TREATMENT OF STROKE YIELDS POSITIVE RATES OF REVASCULARIZATION